UCSF Dermatology Grand Rounds 22 January 2025
UCSF Dermatology Grand Rounds - Lecture Only
Patient Viewing Cancelled
ZOOM
Innovation and Equity: The UCSF Approach to Hidradenitis Suppurativa Care
Jazzmin Williams, MD, PGY-2 Dermatology Resident, Herbert Castillo Valladares, MD, MHS, Assistant Clinical Professor of Dermatology, Daniel M. Klufas, MD, Assistant Clinical Professor, Department of Dermatology, Ernest Lee, MD, PhD,Assistant Clinical Professor, Department of Dermatology, Haley Naik, MD, Associate Professor, Department of Dermatology, UCSF
Objectives:
Apply and combine cutting-edge medical and procedural treatment strategies for hidradenitis suppurativa.
Assess and address social determinants of health that may impact management of hidradenitis suppurativa.
Describe research innovations in our understanding our hidradenitis suppurativa etiology, clinical course and therapeutic targets.
Speaker Disclosures: Jazzmin Williams, MD, Herbert Castillo Valladares, MD, MHS, Daniel M. Klufas, MD, Assistant Clinical Professor, and Ernest Lee, MD, PhD have all stated that they have no financial relationships to disclose. Haley Naik, MD, is a consultant for Abbvie, Medscape, Sonoma Biotherapeutics, Union Chimique Belge (UCB), and Novartis, a stock Shareholder of Radera, Inc. and an employee of JAMA Dermatology and Hidradenitis Suppurativa Foundation.
Moderator Disclosures: Herbert Castillo Valladares, MD has stated that he has no financial relationships to disclose.
Planner Disclosures: Hunter Shain, PhD has disclosed that he has an industry sponsored research agreement with Kenview. Kelly Cordoro, MD and Amanda Twigg, MD have stated they have no relationships to disclose.
